BG3515-5 US 5mL BioGlue Surgical Adhesive. BioGlue Surgical Adhesive (BioGlue) is indicated for use as an adjunct to standard methods of achieving hemostasis (such as sutures and staples) in adult patients in open surgical repair of of large vessels (such as aorta, femoral, and carotid arteries).
Publicado el 11 de junio de 2014 · Inicio del retiro: 25 de abril de 2014
Resumen
FDA registra el retiro Z-1674-2014 de dispositivos médicos de Clase II, publicado el 11 de junio de 2014 e iniciado el 25 de abril de 2014. Empresa responsable: CryoLife, Inc.; Estado: Finalizado; Cantidad reportada: 6190 units; Lote: 12MUV034, 12MUX035, 12MUV069, 12MUV037, 12MUV038, 12MUV040, 12MUV041, 12MUV042, 12MUV043, 12MUV044, 12MUV045, 12MUV046, 12MUV047, 12MUV048, 12MUV049, 12MUV050, 12MUV051, 12MUV052, 12MUV053, 12MUV054, 12MUV055, 12MUV056, 12MUV057, 12MUV058, 12MUV059, 12MUV060, 12MUV061, 12MUV062, 12MUV063, 12MUV064, 12MUV065, 12MUV067, 12MUV068, 12MUV069, 12MUV070, 12MUV071, 12MUV072, 12MUV073, 12MUV074, 12MUV075, 12MUV076, 13MUV001, 13MUV002, 13MUV003, 13MUV004,. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Serum albumin component monomer failed to meet internally established end of shelf-life specification.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- CryoLife, Inc.
- Distribuidor
- Distributed Nationwide including Puerto Rico and the states of AL, AK,AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, MD, MA, MI, MN, MS, MO, MT, NV, NH, NJ, NM , NY, NC, ND, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WV, and WI.
- Lote
- 12MUV034, 12MUX035, 12MUV069, 12MUV037, 12MUV038, 12MUV040, 12MUV041, 12MUV042, 12MUV043, 12MUV044, 12MUV045, 12MUV046, 12MUV047, 12MUV048, 12MUV049, 12MUV050, 12MUV051, 12MUV052, 12MUV053, 12MUV054, 12MUV055, 12MUV056, 12MUV057, 12MUV058, 12MUV059, 12MUV060, 12MUV061, 12MUV062, 12MUV063, 12MUV064, 12MUV065, 12MUV067, 12MUV068, 12MUV069, 12MUV070, 12MUV071, 12MUV072, 12MUV073, 12MUV074, 12MUV075, 12MUV076, 13MUV001, 13MUV002, 13MUV003, 13MUV004,
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDAOn-X Prosthetic Heart Valve Product Usage: Indicated for the replacement of diseased, damaged, or19 de julio de 2017
- FDABioGlue Surgical Adhesive, Model/Catalog Number BG3510-5-J5 de julio de 2017
- FDAMedrad Continuum MR Infusion system- non-wireless system The MEDRAD Continuum MR Infusion System is designed11 de junio de 2014
- FDAIntegra Licox Test Kit REF BC10R Rx Only An accessory provided for use with the LCXO2 and AC31 PtO2 Monitors.11 de junio de 2014
- FDALily Bloom's Kitchen Chocolate Coconut Poparoons11 de junio de 2014
- FDAPulmonary Hemi-Artery SG Used in heart surgery29 de enero de 2014
Preguntas sobre este retiro
¿BG3515-5 US 5mL BioGlue Surgical Adhesive. BioGlue Surgical Adhesive (BioGlue) is indicated for use as an adjunct to standard methods of achieving hemostasis (such as sutures and staples) in adult patients in open surgical repair of of large vessels (such as aorta, femoral, and carotid arteries). fue retirado del mercado?
Sí. FDA publicó el retiro Z-1674-2014 el 11 de junio de 2014. Peligro reportado: Serum albumin component monomer failed to meet internally established end of shelf-life specification.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter